Dao Min Zhu

Dr. Dao Min Zhu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
CZCuizhen Zhu
Cuizhen Zhu
YZYu Zhang
Yu Zhang
TWTing Wang
Ting Wang
YLYezhe Lin
Yezhe Lin
JYJiakuai Yu
Jiakuai Yu
DZDao Min Zhu
Dao Min Zhu
Objective: Epidemiological evidence indicated a relationship between vitamin D (VD) and depression with anxiety, but their therapeutic relationship has not been fully elucidated. This study aimed to examine whether VD supplementation would relieve symptoms in patients with depression and anxiety with low serum 25‐hydroxy VD [25(OH) D] levels.Method: Participants with low 25(OH)D levels were randomized to control or daily VD group and were followed up for 6 months. Serum concentrations of 25(OH) D were measured using commercial kits. Psychological symptoms were evaluated with the Hamilton Depression Rating Scale‐17 (HAMD‐17), Revised Social Anhedonia Scale (RSAS), Revised Physical Anhedonia scale (RPAS), and Hamilton Anxiety Rating Scale‐14 (HAMA‐14). The trial was listed in the trial registration (http://www.medresman.org.cn/uc/index.aspx; NTR number: ChiCTR2000030130).Results: In this clinical population, no significant difference in depression symptoms was detected between VD group and control group at both baseline and at the endpoint of our study. The HAMD‐17, RSAS, and RPAS scores did not change significantly between VD and control groups from baseline to endpoint (all p > .05). However, there was a significant difference in time effect of the total HAMA‐14 scores between the two groups (β [95% Cl] = −2.235 [−3.818, −0.653], p = .006).Conclusions: Vitamin D supplementation could improve the anxiety symptoms but not depressive symptoms in depressive patients with low VD level after the 6‐month intervention.

1 June 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JZJiajia Zhu
Jiajia Zhu
YZYu Zhang
Yu Zhang
BZBiao Zhang
Biao Zhang
YYYing Yang
Ying Yang
YWYajun Wang
Yajun Wang
YYYongqiang Yu
Yongqiang Yu

7 July 2025 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
SLSiyu Liu
Siyu Liu
YLYifei Li
Yifei Li
YSYu Shi
Yu Shi
ZRZhonghao Rao
Zhonghao Rao
YZYongqi Zhang
Yongqi Zhang
JZJiajia Zhu
Jiajia Zhu
Background: Compelling evidence claims that gut microbial dysbiosis may be causally associated with major depressive disorder (MDD), with a particular focus on Alistipes. However, little is known about the potential microbiota–gut–brain axis mechanisms by which Alistipes exerts its pathogenic effects in MDD. Methods: We collected data from 16S rDNA amplicon sequencing, untargeted metabolomics, and multimodal brain magnetic resonance imaging from 111 MDD patients and 102 healthy controls. We used multistage linked analyses, including group comparisons, correlation analyses, and mediation analyses, to explore the relationships between the gut microbiome (Alistipes), fecal metabolome, brain imaging, and behaviors in MDD. Results: Gut microbiome analysis demonstrated that MDD patients had a higher abundance of Alistipes relative to controls. Partial least squares regression revealed that the increased Alistipes was significantly associated with fecal metabolome in MDD, involving a range of metabolites mainly enriched for amino acid, vitamin B, and bile acid metabolism pathways. Correlation analyses showed that the Alistipes-related metabolites were associated with a wide array of brain imaging measures involving gray matter morphology, spontaneous brain function, and white matter integrity, among which the brain functional measures were, in turn, associated with affective symptoms (anxiety and anhedonia) and cognition (sustained attention) in MDD. Of more importance, further mediation analyses identified multiple significant mediation pathways where the brain functional measures in the visual cortex mediated the associations of metabolites with behavioral deficits. Conclusion: Our findings provide a proof of concept that Alistipes and its related metabolites play a critical role in the pathophysiology of MDD through the microbiota–gut–brain axis.

1 December 2021 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
XLXueying Li
Xueying Li
YZYu Zhang
Yu Zhang
CMChun Meng
Chun Meng
CZCun Zhang
Cun Zhang
WZWenming Zhao
Wenming Zhao
JZJiajia Zhu
Jiajia Zhu

27 February 2024 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
XLXinyu Li
Xinyu Li
JYJiakuai Yu
Jiakuai Yu
SJShuo Jiang
Shuo Jiang
LFLiang Fang
Liang Fang
YLYifei Li
Yifei Li
DZDao Min Zhu
Dao Min Zhu
Background: Mood disorders are strongly associated with melatonin disturbances. However, it is unclear whether there is a difference in melatonin concentrations and melatonin circadian rhythm profiles between depression and bipolar disorder. In addition, the relationship between anhedonia, a common symptom of affective disorders, and its melatonin circadian rhythm remains under-investigated. Methods: Thirty-four patients with depression disorder, 20 patients diagnosed with bipolar disorder and 21 healthy controls participated in this study. The Revised Physical Anhedonia Scale (RPAS) was performed to assess anhedonia. Saliva samples were collected from all subjects at fixed time points (a total of 14 points) in two consecutive days for measuring the melatonin concentrations to fit circadian rhythms of subjects. Melatonin circadian rhythms were compared between the three groups using ANOVA. Partial correlation analysis and linear regression analysis were used to explore the correlation between melatonin rhythm variables and anhedonia. Results: We found that the peak phase of melatonin in the depression group was significantly advanced compared to the control group (P < 0.001) and the bipolar disorder group (P = 0.004). The peak phase of melatonin and RPAS showed a negative correlation (P = 0.003) in depression patients, which was also demonstrated in the multiple linear regression model (B=-2.47, P = 0.006). Conclusions: These results suggest that circadian rhythms of melatonin are differentiated in depression and bipolar disorder and correlate with anhedonia in depression. Future research needs to explore the neurobiological mechanisms linking anhedonia and melatonin circadian rhythms in depressed patients.

8 January 2022 in Archives of Women's Mental Health
Verified
Journal Article
Closed access
PDF file
SMShuangshuang Ma
Shuangshuang Ma
XYXiaoguang Yin
Xiaoguang Yin
RTRuixue Tao
Ruixue Tao
XJXiaomin Jiang
Xiaomin Jiang
JXJun Xie
Jun Xie
PZPeng Zhu
Peng Zhu